Menu
X

About Mary Bird Perkins Cancer Center – Covington

HISTORY

Since 1998, Mary Bird Perkins Cancer Center has worked closely with St. Tammany Parish Hospital in Covington to provide cancer services to the Northshore community. In April 2012, the partnership took a significant step forward with the opening of the state-of-the-art Mary Bird Perkins Cancer Center at St. Tammany Parish Hospital.

The new comprehensive cancer facility, which opened in 2012, provides the full spectrum of cancer care, from prevention and early detection to diagnosis, treatment, recovery and survivorship. The Center’s services include chemotherapy, radiation therapy, surgery, clinical research trials, patient navigation, free community screenings, education and more. These services are readily available to Northshore residents where it matters most – close to family and close to home.

Nationally accredited with commendation and recognized for excellence in cancer care by the American College of Surgeons Commission on Cancer, Mary Bird Perkins Cancer Center at St. Tammany Parish Hospital offers cancer patients and families access to advanced technology and clinical expertise. The Center’s diagnostic and treatment technologies include the Elekta Infinity linear accelerator that allows for faster, more accurate treatments.

The Cancer Center occupies more than 20,000-square-feet and is located on the campus of STPH. Access is at street level for outpatients while hospital inpatients are transported for treatment via a sky bridge connecting the two facilities. Throughout the Center, the hospital’s Foundation Healing Arts Initiative has installed various pieces of art created by local artists to enhance the patient experience and healing process. One special tribute piece that hangs in the waiting room is dedicated in honor of Rufus Upton Lea and his wife Marianne Spetz Lea, both of whom received care at the Center.

COMMUNITY REPORT

Previous Reports:

ACCREDITATIONS

AMERICAN COLLEGE OF RADIOLOGY

Mary Bird Perkins Cancer Center in Covington has been awarded a three-year term of reaccreditation in nuclear medicine as the result of a recent review by the American College of Radiology (ACR), Committee on Nuclear Medicine Accreditation. Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material, administered or by the patient, to diagnose or treat a variety of disease, including many types of cancers, heart disease and certain other abnormalities within the body.

The ACR gold seal of accreditation represents the highest level of image quality and patient safety. It is awarded only to facilities meeting ACR Practice Parameters and Technical Standards after a peer-review evaluation by board-certified physicians and medical physicists who are experts in the field. Image quality, personnel qualifications, adequacy of facility equipment, quality control procedures and quality assurance programs are assessed. The findings are reported to the ACR Committee on Accreditation, which subsequently provides the practice with a comprehensive report that can be used for continuous practice improvement.

The ACR, founded in 1924, is a professional medical society dedicated to serving patients and society by empowering radiology professionals to advance the practice, science and professions of radiological care. The College serves more than 37,000 diagnostic/interventional radiologists, radiation oncologists, nuclear medicine physicians, and medical physicists with programs focusing on the practice of medical imaging and radiation oncology and the delivery of comprehensive health care services.

LUNG CANCER ALLIANCE

Mary Bird Perkins Cancer Center in Covington is a designated Screening Center of Excellence by the Lung Cancer Alliance. This acknowledges organizations adhering to LCA’s quality standards, the National Framework of Excellence, which includes: utilizing quality screening methods, employing recommended criteria for selecting high-risk individuals for screening and educating about risks and benefits, and providing evaluation and follow-up with a multidisciplinary team of experts.

For more information read the press release here

COMMISSION ON MEDICAL PHYSICS EDUCATION PROGRAMS ACCREDITATION

The Commission on Medical Physics Education Programs (CAMPEP) has granted full reaccreditation to the Mary Bird Perkins Cancer Center Medical Physics Residency Program. Mary Bird Perkins is the first center in Louisiana to establish such a program, helping provide highly specialized professionals to the workforce and enhanced care for cancer patients. Mary Bird Perkins has been accredited by CAMPEP since 2014.

For more information, read the press release here.

ASSOCIATION OF COMMUNITY CANCER CENTER’S INNOVATOR AWARD

Mary Bird Perkins Cancer Center was been named an Innovator Award recipient by the Association of Community Cancer Centers for the organization’s early detection program. Through the Innovator Award, organizations are recognized for their forward-thinking, pioneering solutions for the effective delivery of cancer care. Mary Bird’s early detection program is working to help reduce mortality especially among the uninsured and underinsured adults who are traditionally underserved and experience even higher rates of mortality than the general population.

For more information, read the press release here.

NATIONAL CANCER INSTITUTE COMMUNITY ONCOLOGY RESEARCH PROGRAM AWARD

Louisiana and Gulf South residents have more options to seek advanced cancer treatment, thanks to a $5.6 million National Cancer Institute Community Oncology Research Program (NCORP) award. Presented to LSU Health Sciences Center-New Orleans by the National Cancer Institute (NCI), the NCORP grant continues through 2019 and focuses on conducting multi-site cancer clinical trials and cancer care delivery research studies in many Louisiana communities. Working in partnership with LSU-New Orleans is grant collaborators Mary Bird Perkins and LSU Health Sciences Center-Shreveport, referred to collectively as the Gulf South Minority/Underserved NCI Community Oncology Research Program.

For more information, read the press release here.